Early research (Phase 1)Study completedNCT04208152What this trial is testingA First-in-Human Study of Single and Multiple Doses of anle138b in Healthy SubjectsWho this might be right forHealthy Volunteers MODAG GmbH 68
Early research (Phase 1)Study completedNCT01979406What this trial is testingAscending Dose Study to Assess the Safety and Immunogenicity of Adenovirus Anthrax Vector Candidate VaccinesWho this might be right forAnthrax Infection Emergent BioSolutions 120
Large-scale testing (Phase 3)Ended earlyNCT00998764What this trial is testingA Long-Term Safety And Tolerability Extension Study Of Bapineuzumab In Alzheimer Disease PatientsWho this might be right forAlzheimer Disease Pfizer 494
Early research (Phase 1)Study completedNCT02360657What this trial is testingStudy Investigating the Effects of JNJ-54861911 on Amyloid-beta Processing in Cerebrospinal Fluid (CSF) and Plasma in Japanese Participants Asymptomatic at Risk for Alzheimer DementiaWho this might be right forAlzheimer's Disease Janssen Pharmaceutical K.K. 18
Not applicableUnknownNCT02759159What this trial is testingThe Study of Mechanism of Alzheimer's Disease Using Acupuncture Based on fMRIWho this might be right forAlzheimer's Disease Xuanwu Hospital, Beijing 120
Early research (Phase 1)Study completedNCT01978548What this trial is testingEvaluate the Effects of JNJ-54861911 on Amyloid Beta Processing in Cerebrospinal Fluid and Plasma in Patients With Prodromal Alzheimer's DiseaseWho this might be right forAlzheimer Disease Janssen Research & Development, LLC 45
Early research (Phase 1)Study completedNCT04685265What this trial is testingAssess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of anle138b in Parkinson's DiseaseWho this might be right forParkinson Disease MODAG GmbH 70
Large-scale testing (Phase 3)Ended earlyNCT00667810What this trial is testingStudy Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease PatientsWho this might be right forAlzheimer Disease Pfizer 901
Early research (Phase 1)Study completedNCT00988624What this trial is testingA Study In Healthy Volunteers To Estimate The Pharmacokinetics Of Four Modified-Release Formulations Of Dimebon (Latrepirdine)Who this might be right forAlzheimer's DiseaseHuntington Disease Pfizer 20
Early research (Phase 1)Study completedNCT01989533What this trial is testingStudy of Safety and Immunogenicity of HIV Vaccines in Healthy VolunteersWho this might be right forVaccine Response National Institute of Allergy and Infectious Diseases (NIAID) 62
Large-scale testing (Phase 3)UnknownNCT01094340What this trial is testingThalidomide for Patients With Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Banner Health 20
Early research (Phase 1)Looking for participantsNCT06372821What this trial is testingA Trial Evaluating the Effect of NIO752 on Tau Synthesis Measured by a Process Known as SILKWho this might be right forAlzheimer DiseaseAutosomal Dominant Alzheimer Disease Due to Mutation of Presenilin 1 (Disorder)Autosomal Dominant Alzheimer Disease Due to Mutation of Presenilin 2 (Disorder)+1 more University College, London 10
Large-scale testing (Phase 3)Study completedNCT05108922What this trial is testingDonanemab (LY3002813) Compared With Aducanumab in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 4)Who this might be right forMild Cognitive Impairment (MCI)Alzheimer Disease Eli Lilly and Company 148
Early research (Phase 1)Active Not RecruitingNCT06332339What this trial is testingClinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of 16055 NFL Delta Gly4 Env Protein Trimer and Trimer 4571 Combined With 3M-052-AF + Alum Adjuvant and Ad4-Env145NFL Viral Particles as Heterologous Prime-boost Regimens in Adult Participants Without HIV.Who this might be right forHIV National Institute of Allergy and Infectious Diseases (NIAID) 45
Early research (Phase 1)Study completedNCT05532358What this trial is testingA Drug-Drug Interaction Study to Assess the CYP1A2 and CYP3A4 Interaction Potential of TEV-56286 (anle138b)Who this might be right forHealthy Volunteers MODAG GmbH 54
Not applicableLooking for participantsNCT06733714What this trial is testingAssociation of Transcranial Alternating Current Stimulation with Digital Cognitive Training for Cognitive Remediation in Older AdultsWho this might be right forCognitive DysfunctionAlzheimer DiseaseMild Cognitive Impairment+8 more Universidade Federal do Rio de Janeiro 40
Testing effectiveness (Phase 2)Study completedNCT04693520What this trial is testingBiomarker Effects of ALZ-801 in APOE4 Carriers With Early Alzheimer's DiseaseWho this might be right forEarly Alzheimer's Disease Alzheon Inc. 84
Early research (Phase 1)Study completedNCT00901498What this trial is testingRelative Bioavailability Study of Four Experimental Formulations for Alzheimer's DiseaseWho this might be right forAlzheimer's DiseaseHealthy Bristol-Myers Squibb 36
Testing effectiveness (Phase 2)Ended earlyNCT00582855What this trial is testingEffect of AQW051 in Patients With Memory ImpairmentWho this might be right forMild Alzheimer's DiseaseAmnestic Mild Cognitive Impairment Novartis Pharmaceuticals 54
Post-approval studies (Phase 4)Not Yet RecruitingNCT06911944What this trial is testingAmyloid Lowering for Alzheimer's in Down's With Donanemab InvestigationWho this might be right forDown Syndrome (DS)Down Syndrome (Trisomy 21)Alzheimer Disease+1 more Michael Rafii, MD, PhD 60